ENALAPRILAT Drug Patent Profile
✉ Email this page to a colleague
When do Enalaprilat patents expire, and when can generic versions of Enalaprilat launch?
Enalaprilat is a drug marketed by Chartwell Injectable, Dr Reddys, Hikma Farmaceutica, and Hospira. and is included in six NDAs.
The generic ingredient in ENALAPRILAT is enalaprilat. There are eight drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the enalaprilat profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Enalaprilat
A generic version of ENALAPRILAT was approved as enalaprilat by CHARTWELL INJECTABLE on August 22nd, 2000.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ENALAPRILAT?
- What are the global sales for ENALAPRILAT?
- What is Average Wholesale Price for ENALAPRILAT?
Summary for ENALAPRILAT
| US Patents: | 0 |
| Applicants: | 4 |
| NDAs: | 6 |
| Finished Product Suppliers / Packagers: | 3 |
| Raw Ingredient (Bulk) Api Vendors: | 73 |
| Clinical Trials: | 11 |
| Patent Applications: | 4,469 |
| DailyMed Link: | ENALAPRILAT at DailyMed |
Recent Clinical Trials for ENALAPRILAT
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| University of Maryland, Baltimore | Phase 4 |
| University of Guadalajara | Phase 2 |
| Ethicare GmbH | Phase 2/Phase 3 |
Pharmacology for ENALAPRILAT
| Drug Class | Angiotensin Converting Enzyme Inhibitor |
| Mechanism of Action | Angiotensin-converting Enzyme Inhibitors |
| Physiological Effect | Decreased Blood Pressure |
Medical Subject Heading (MeSH) Categories for ENALAPRILAT
US Patents and Regulatory Information for ENALAPRILAT
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chartwell Injectable | ENALAPRILAT | enalaprilat | INJECTABLE;INJECTION | 075634-001 | Aug 22, 2000 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Hospira | ENALAPRILAT | enalaprilat | INJECTABLE;INJECTION | 075456-001 | Aug 22, 2000 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Dr Reddys | ENALAPRILAT | enalaprilat | INJECTABLE;INJECTION | 075578-001 | Aug 22, 2000 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Hikma Farmaceutica | ENALAPRILAT | enalaprilat | INJECTABLE;INJECTION | 078687-001 | Dec 23, 2008 | AP | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Hospira | ENALAPRILAT | enalaprilat | INJECTABLE;INJECTION | 075571-001 | Aug 22, 2000 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Hospira | ENALAPRILAT | enalaprilat | INJECTABLE;INJECTION | 075458-001 | Aug 22, 2000 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
